Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Neutropenia 1Neurotoxicity Syndromes 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Ovarian Epithelial 1Anemia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Filgrastim 7pegylated granulocyte colony-stimulating factor 5pegfilgrastim 5Cytarabine 4Ciprofloxacin 4Cefepime 4Vancomycin 3Leucovorin 3Fluorouracil 3Amikacin 3trifluridine tipiracil drug combination 2Piperacillin, Tazobactam Drug Combination 2Methylprednisolone 2Meropenem 2Irinotecan 2Etoposide 2Daptomycin 2Cisplatin 2Ceftazidime 2ziprasidone 1trilaciclib 1sargramostim 1niraparib 1liposomal amphotericin B 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neutropenia × 2,2'-dithiodiethanesulfonic acid × Clear all
NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
160 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡